Generic drug manufacturers are not insulated from lawsuits by an FDA approval process that certifies such drugs as the “bioequivalent” of their brand-name predecessors, a federal judge has ruled. The judge refused to dismiss a suit brought by consumers who were taking Wellbutrin, a brand-name antidepressant, and who claim they had side effects upon switching to a generic. The suit alleges that two drug manufacturers failed to warn the public about differences that affected the release of the product’s active ingredient.

An Oklahoma jury has found the maker of Botox negligent and awarded $15 million to a doctor who says she suffered botulism after using the anti-wrinkle drug.

A New York federal judge has held that a baggage screener at John F. Kennedy International Airport who tested positive for marijuana cannot avoid being fired on the grounds that his test results were allegedly the product of secondhand smoke.

A new set of court rules that go into effect in California in the New Year offer some of the most significant changes in the field of minors’ personal injury claims in years, lawyers on both sides of the issue say. The rules, the product of two years of negotiation among the plaintiffs bar, defense counsel and judges, address the complex and confusing area of law known as minor’s compromise.

This edition of Wainberg’s Society Meetings Including Rules of Order is an updated version of the very popular first edition that was published in 1992. Easy reading and authoritative discussion of many of the issues that would arise at, before, or during, the holding of meetings of directors or members of societies make this book an indispensable reference guide for members of various charities and other non-share capital corporations. Editors Hartley R.